2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-27
DOI
10.1038/s41598-017-07330-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations
- (2016) Sofia Vasilakaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A 2 with reduced lipophilicity
- (2016) Georgia Antonopoulou et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016)
- (2016) Maroula G. Kokotou et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure–Activity Relationships
- (2016) Varnavas D. Mouchlis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthetic and Natural Inhibitors of Phospholipases A2: Their Importance for Understanding and Treatment of Neurological Disorders
- (2015) Wei-Yi Ong et al. ACS Chemical Neuroscience
- Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation
- (2015) Nicholas S. Kirkby et al. FASEB JOURNAL
- Cytosolic phospholipase A2: physiological function and role in disease
- (2015) Christina C. Leslie JOURNAL OF LIPID RESEARCH
- Chiral Surfactant-Type Catalyst: Enantioselective Reduction of Long-Chain Aliphatic Ketoesters in Water
- (2015) Zechao Lin et al. JOURNAL OF ORGANIC CHEMISTRY
- Membranes serve as allosteric activators of phospholipase A2, enabling it to extract, bind, and hydrolyze phospholipid substrates
- (2015) Varnavas D. Mouchlis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples
- (2014) Yan Wang et al. JOURNAL OF CHROMATOGRAPHY A
- Inhibition of Group IVA Cytosolic Phospholipase A2 by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo
- (2014) George Kokotos et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic Acids as New Indole-Based Cytosolic Phospholipase A2α Inhibitors
- (2014) Toshiyuki Tomoo et al. JOURNAL OF MEDICINAL CHEMISTRY
- New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2
- (2013) Victoria Magrioti et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phospholipase A2inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)
- (2013) Victoria Magrioti et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
- (2011) Edward A. Dennis et al. CHEMICAL REVIEWS
- Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype
- (2011) Paul C. Norris et al. JOURNAL OF LEUKOCYTE BIOLOGY
- 1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α: Effect of Substituents in Position 3 of the Indole Scaffold on Inhibitory Potency, Metabolic Stability, Solubility, and Bioavailability
- (2010) Stefanie Bovens et al. JOURNAL OF MEDICINAL CHEMISTRY
- 1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α with Reduced Lipophilicity: Synthesis, Biological Activity, Metabolic Stability, Solubility, Bioavailability, And Topical in Vivo Activity
- (2010) Andreas Drews et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent and Selective Fluoroketone Inhibitors of Group VIA Calcium-Independent Phospholipase A2
- (2010) George Kokotos et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent progress in phospholipase A2 research: From cells to animals to humans
- (2010) Makoto Murakami et al. PROGRESS IN LIPID RESEARCH
- Location of Inhibitors Bound to Group IVA Phospholipase A2Determined by Molecular Dynamics and Deuterium Exchange Mass Spectrometry
- (2009) John E. Burke et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2α: Synthesis, biological activity, metabolic stability, and solubility
- (2008) Alexandra Fritsche et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Indole Cytosolic Phospholipase A2α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib
- (2008) John C. McKew et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of Polyfluoro Ketones for Selective Inhibition of Human Phospholipase A2Enzymes
- (2008) Constantinos Baskakis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy
- (2007) Katherine L. Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More